Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Ingredion
INGR
$6.63B
| $13.7M | ﹤0.01% |
99,844
+18,601
| +23% | +$2.62M |
|
2552
CALL
Semtech
SMTC
$13.1B
| $13.7M | ﹤0.01% |
221,800
-7,800
| -3% | -$412K |
|
|
PPLI
2553
People Inc
PPLI
$3.01B
| $13.7M | ﹤0.01% |
387,346
-166,050
| -30% | -$6.65M |
|
2554
VanEck Gold Miners ETF
GDX
$27.5B
| $13.7M | ﹤0.01% |
403,925
+104,331
| +35% | +$4M |
|
2555
Root
ROOT
$797M
| $13.7M | ﹤0.01% |
188,541
-4,269
| -2% | -$295K |
|
2556
CALL
Globe Life
GL
$14.1B
| $13.7M | ﹤0.01% |
122,600
-23,000
| -16% | -$2.48M |
|
2557
AGCO
AGCO
$7.1B
| $13.7M | ﹤0.01% |
146,208
+119,211
| +442% | +$11.5M |
|
2558
CALL
Plains GP Holdings
PAGP
$5.11B
| $13.7M | ﹤0.01% |
743,300
-117,500
| -14% | -$2.18M |
|
2559
Union Pacific
UNP
$174B
| $13.6M | ﹤0.01% |
59,825
-322,538
| -84% | -$76.4M |
|
2560
PUT
Markel Group
MKL
$22.9B
| $13.6M | ﹤0.01% |
7,900
+500
| +7% | +$830K |
|
|
TWO
2561
Two Harbors Investment
TWO
$1.27B
| $13.6M | ﹤0.01% |
1,151,577
-103,718
| -8% | -$1.26M |
|
2562
Dropbox
DBX
$7.48B
| $13.6M | ﹤0.01% |
452,669
+443,285
| +4,724% | +$12.2M |
|
|
EXAS
2563
PUT
DELISTED
Exact Sciences
EXAS
| $13.6M | ﹤0.01% |
242,000
-36,700
| -13% | -$2.28M |
|
2564
TechnipFMC
FTI
$30.8B
| $13.5M | ﹤0.01% |
+467,505
| New | +$13.3M |
|
2565
CALL
Western Alliance Bancorporation
WAL
$8.98B
| $13.5M | ﹤0.01% |
161,500
-21,500
| -12% | -$1.89M |
|
|
SWTX
2566
DELISTED
SpringWorks Therapeutics
SWTX
| $13.5M | ﹤0.01% |
373,231
+242,525
| +186% | +$8.47M |
|
|
2567
Plains GP Holdings
PAGP
$5.11B
| $13.5M | ﹤0.01% |
733,348
-330,549
| -31% | -$6.14M |
|
2568
CALL
Western Midstream Partners
WES
$20.2B
| $13.5M | ﹤0.01% |
350,700
-1,400
| -0.4% | -$54K |
|
2569
Wabtec
WAB
$50.5B
| $13.5M | ﹤0.01% |
71,085
+48,182
| +210% | +$9.33M |
|
|
PARA
2570
CALL
DELISTED
Paramount Global Class B
PARA
| $13.5M | ﹤0.01% |
1,287,600
-322,200
| -20% | -$3.46M |
|
2571
CALL
Insmed
INSM
$27B
| $13.5M | ﹤0.01% |
195,000
+113,400
| +139% | +$8.17M |
|
2572
Ally Financial
ALLY
$13.7B
| $13.5M | ﹤0.01% |
373,524
+347,963
| +1,361% | +$12.6M |
|
2573
Loar Holdings
LOAR
$7.25B
| $13.4M | ﹤0.01% |
+181,805
| New | +$14.9M |
|
2574
Aecom
ACM
$8.12B
| $13.4M | ﹤0.01% |
125,771
+114,553
| +1,021% | +$12.5M |
|
2575
CALL
ProShares UltraPro Dow 30
UDOW
$924M
| $13.4M | ﹤0.01% |
283,800
+91,600
| +48% | +$4.63M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.